Literature DB >> 27862250

Prenatal myelomeningocele repair: Do bladders better?

Maya Horst1, Luca Mazzone2, Thomas Schraner3, Christine Bodmer1, Ueli Möhrlen4, Martin Meuli4, Rita Gobet1.   

Abstract

AIMS: Prenatal myelomeningocele (MMC) repair has been proven to significantly reduce the need for hydrocephalus shunting and improve lower-extremity motor outcomes. The aim of this study was to evaluate the effect of prenatal MMC repair on the urological outcome.
METHODS: All patients who underwent fetal MMC repair at our institution are followed prospectively. Assessments include medical history, renal and bladder ultrasound, voiding cystourethrogram and urodynamic study, need for clean intermittent catheterization (CIC) and anticholinergics, and the occurrence of urinary tract infections (UTI).
RESULTS: Of the 30 patients who underwent prenatal MMC closure from December 2010 to December 2015, eight patients with a postnatal follow-up of at least 2 years were included in this study and compared with eight patients after postnatal MMC repair. The level of the bony spinal defect was similar in both groups. Urological evaluation at 2 years revealed normal bladder function in 50% after prenatal repair. Neurogenic bladder dysfunction requiring CIC and anticholinergic therapy was seen in 50% in the prenatal and in 100% in the postnatal group. Significant bladder wall thickening was found in 37.5% and 87.5%, respectively. Febrile UTIs occurred in 37.5% in the prenatal and 62.5% in the postnatal group during the observation period.
CONCLUSIONS: Our data suggest a positive effect of prenatal MMC closure on lower urinary tract function. The long-term significance of these results remains unclear. Therefore, continued close monitoring of renal and bladder function are mandatory.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  fetal surgery; myelomeningocele; neurogenic; spina bifida; urinary bladder; urodynamics

Mesh:

Year:  2016        PMID: 27862250     DOI: 10.1002/nau.23174

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  5 in total

1.  Low level myelomeningoceles: do they need prenatal surgery?

Authors:  Pierre-Aurelien Beuriat; Isabelle Poirot; Frederic Hameury; Delphine Demede; Kieron J Sweeney; Alexandru Szathmari; Federico Di Rocco; Carmine Mottolese
Journal:  Childs Nerv Syst       Date:  2019-03-27       Impact factor: 1.475

Review 2.  Fetal myelomeningocele repair: a narrative review of the history, current controversies and future directions.

Authors:  Kaeli J Yamashiro; Diana L Farmer
Journal:  Transl Pediatr       Date:  2021-05

3.  Preclinical stem cell therapy in fetuses with myelomeningocele: A systematic review and meta-analysis.

Authors:  Yada Kunpalin; Sindhu Subramaniam; Silvia Perin; Mattia F M Gerli; Jan Bosteels; Sebastien Ourselin; Jan Deprest; Paolo De Coppi; Anna L David
Journal:  Prenat Diagn       Date:  2021-01-11       Impact factor: 3.242

4.  In utero myelomeningocele repair and high-risk bladder pattern. a prospective study.

Authors:  Antonio Macedo; Sérgio Leite Ottoni; Antonio Moron; Sergio Cavalheiro; Marcela Leal da Cruz
Journal:  Int Braz J Urol       Date:  2022 Jul-Aug       Impact factor: 3.050

Review 5.  Emerging magnetic resonance imaging techniques in open spina bifida in utero.

Authors:  Andras Jakab; Kelly Payette; Luca Mazzone; Sonja Schauer; Cécile Olivia Muller; Raimund Kottke; Nicole Ochsenbein-Kölble; Ruth Tuura; Ueli Moehrlen; Martin Meuli
Journal:  Eur Radiol Exp       Date:  2021-06-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.